Cerus (NASDAQ:CERS) is one of today's best performing low-priced stocks, up 5.3% to $4.78 on 1.1x average daily volume. Cerus has traded 780,000 shares thus far today, vs. average volume of 709,000 shares per day. The stock has outperformed the Dow (5.3% to the Dow's 0.5%) and outperformed the S&P 500 (5.3% to the S&P's 0.5%) during today's trading.
Over the past year, Cerus has traded in a range of $2.68 to $4.82 and is now at $4.78, 78% above that low. Over the last five market days, the 200-day moving average (MA) has gone up 0.5% while the 50-day MA has advanced 2.3%.
Cerus has overhead space with shares priced $4.78, or 23.5% below the average consensus analyst price target of $6.25. The stock should find initial support at its 50-day moving average (MA) of $3.79 and further support at its 200-day MA of $3.38.
Cerus Corporation develops systems designed to enhance the safety of blood transfusions. The Company's systems inactivate pathogens in blood components and inactivate white blood cells, which are responsible for a variety of adverse transfusion reactions. Cerus' platform technologies prevent viral, bacterial, and cellular replication.